Barts and The London NHS Trust -

Retinoblastoma Genetic Screening Unit - pathology and pharmacy building at Royal London Hospital, photograph by Peter Cook, and DNA helix

The Retinoblastoma Genetic Screening Unit is one of only two genetics centres for retinoblastoma (a form of eye cancer) in England and Wales. We provide a genetics service for patients and their relatives, performing molecular genetic tests for predisposition to retinoblastoma.

We work closely with our colleagues at Barts and The London's clinical retinoblastoma service, which is a designated provider of retinoblastoma care in the south of England.

The unit participates in the external quality assessment scheme organised by the European Molecular Genetics Quality Network (EMQN) and is fully accredited by Clinical Pathology Accreditation (UK) Ltd (CPA).

News

Children being treated for retinoblastoma, a childhood eye cancer, are benefiting from a recently completed make-over to Barts and The London Retinoblastoma Service at The Royal London Hospital in Whitechapel.

Download our users' manual

This contains all the information needed for genetic counsellors and physicians to submit specimens to the unit. Please ensure you have the parent/guardian's consent before making a request.